enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Medroxyprogesterone acetate - Wikipedia

   en.wikipedia.org/wiki/Medroxyprogesterone_acetate

   DMPA, under brand names such as Depo-Provera and Depo-SubQ Provera 104, is used in hormonal birth control as a long-lasting progestogen-only injectable contraceptive to prevent pregnancy in women. [ 38 ] [ 39 ] It is given by intramuscular or subcutaneous injection and forms a long-lasting depot , from which it is slowly released over a period ...

3. Estradiol cypionate/medroxyprogesterone acetate - Wikipedia

   en.wikipedia.org/wiki/Estradiol_cypionate/medr...

   It is recommended for short-term use and is given once a month by injection into a muscle. [3] Common side effects of EC/MPA include irregular menstrual periods which typically improves with time. [3] Other side effects include blood clots, headache, hair loss, depression, nausea, and breast pain. [3] [4] Use during pregnancy is not recommended ...

4. Progestogen-only injectable contraceptive - Wikipedia

   en.wikipedia.org/wiki/Progestogen-only_inject...

   Medroxyprogesterone acetate (brand names Depo-Provera, Provera, Depo-subQ Provera 104) [4] – 150 mg (intramuscularly) or 104 mg (subcutaneously) every 3 months [3] Norethisterone enanthate (brand names NET EN, Noristerat, Norigest, Doryxas) [ 5 ] – 200 mg (intramuscularly) every 2 months [ 3 ]

5. Progestogen (medication) - Wikipedia

   en.wikipedia.org/wiki/Progestogen_(medication)

   "Unfortunately, there are few long-term clinical studies comparing different progestogens used in [hormone therapy] with respect to cardiovascular outcomes. However, some aspects of potential cardiovascular risk have been examined, namely effects on lipids, vascular function/blood pressure, inflammation, thrombosis, and carbohydrate metabolism.

6. Boxed warning - Wikipedia

   en.wikipedia.org/wiki/Boxed_warning

   As of November 17, 2004, the FDA has required a boxed warning on the Depo-Provera contraceptive injection, due to the risk of significant loss of bone density with long-term use. [ 8 ] In April 2005, FDA advisors requested that Pfizer place a boxed warning on their non-steroidal anti-inflammatory drug Celebrex ( celecoxib ) for cardiovascular ...

7. Hormonal contraception - Wikipedia

   en.wikipedia.org/wiki/Hormonal_contraception

   Contraceptive Technology reports a typical failure rate of 3% per year for the injection Depo-Provera, and 8% per year for most other user-dependent hormonal methods. [10] While no large studies have been done, it is hoped that newer methods which require less frequent action (such as the patch) will result in higher user compliance and ...

8. Comparison of birth control methods - Wikipedia

   en.wikipedia.org/wiki/Comparison_of_birth...

   Different forms of birth control have different potential side effects. Not all, or even most, users will experience side effects from a method. The less effective the method, the greater the risk of pregnancy, and the side effects associated with pregnancy. Minimal or no side effects occur with coitus interruptus, fertility awareness-based ...

9. Long-acting reversible contraceptives - Wikipedia

   en.wikipedia.org/wiki/Long-acting_reversible...

   For some users, these side effects lead them to discontinue use. [23] The most common side effect of the contraceptive implant is irregular bleeding, which includes both reduced and increased levels of bleeding. [24] Other side effects include mood changes and mild insulin resistance. [21]